Design
Review
Authors
Loading...
Guideline discrepancies may influence HFrEF and HFpEF decisions; leaves open the need for harmonized evidence on ARBs, devices, and aldosterone antagonists.
Key points are not available for this paper at this time.
Michel Komajda (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: